TAAR1 and schizophrenia: ,36 Whether this mechanism follows a positive dose–response relationship remains unclear; however, our study provides evidence supporting the potential role of the TAAR1 agonist ulotaront, especially at the already tested 100 mg dose in treating schizophrenia.